Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker

Huan Zhao, Chunlei Zheng, Yizhe Wang, Kezuo Hou, Xianghong Yang, Yang Cheng, Xiaofang Che, Shilin Xie, Shuo Wang, Tieqiong Zhang, Jian Kang, Yunpeng Liu, Dianzhu Pan, Xiujuan Qu, Xuejun Hu, Yibo Fan

Open source

DOI
10.3389/fonc.2026.1904016
Published
2026-07-03
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1904016,
  title = {Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker},
  author = {Huan Zhao and Chunlei Zheng and Yizhe Wang and Kezuo Hou and Xianghong Yang and Yang Cheng and Xiaofang Che and Shilin Xie and Shuo Wang and Tieqiong Zhang and Jian Kang and Yunpeng Liu and Dianzhu Pan and Xiujuan Qu and Xuejun Hu and Yibo Fan},
  year = {2026},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2026.1904016},
  url = {https://doi.org/10.3389/fonc.2026.1904016}
}

RIS

TY  - JOUR
TI  - Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker
AU  - Huan Zhao
AU  - Chunlei Zheng
AU  - Yizhe Wang
AU  - Kezuo Hou
AU  - Xianghong Yang
AU  - Yang Cheng
AU  - Xiaofang Che
AU  - Shilin Xie
AU  - Shuo Wang
AU  - Tieqiong Zhang
AU  - Jian Kang
AU  - Yunpeng Liu
AU  - Dianzhu Pan
AU  - Xiujuan Qu
AU  - Xuejun Hu
AU  - Yibo Fan
PY  - 2026
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1904016
UR  - https://doi.org/10.3389/fonc.2026.1904016
ER  - 

APA

Zhao, H., Zheng, C., Wang, Y., Hou, K., Yang, X., Cheng, Y., Che, X., Xie, S., Wang, S., Zhang, T., Kang, J., Liu, Y., Pan, D., Qu, X., Hu, X., & Fan, Y. (2026). Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1904016

Source records